Anifrolumab (Saphnelo) Gets Green Light for Approval in EU

Anifrolumab, a monoclonal antibody against type I interferon receptor, was approved by the US Food and Drug Administration in July 2021.
International Approvals

source https://www.medscape.com/viewarticle/965126?src=rss